The Hidden Risks of Performance Enhancement: Pharmacists Are Critical to Protecting Athletes in a “Quick-Fix” Era

At the 2026 Sports Pharmacy Summit in Fort Lauderdale, Travis Tygart, CEO of the United States Anti-Doping Agency (USADA), delivered a keynote that reframed the modern doping conversation—not as an isolated issue of elite misconduct, but as a growing public health concern shaped by accessibility, misinformation, and cultural pressure.¹